Correlation Between Pfizer and Barclays Capital

Can any of the company-specific risk be diversified away by investing in both Pfizer and Barclays Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Barclays Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Barclays Capital, you can compare the effects of market volatilities on Pfizer and Barclays Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Barclays Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Barclays Capital.

Diversification Opportunities for Pfizer and Barclays Capital

-0.93

Correlation Coefficient

Pfizer  Barclays Capital

Pay attention - limited upside

The 3 months correlation between Pfizer and Barclays is -0.93. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Barclays Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Barclays Capital and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Barclays Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Barclays Capital has no effect on the direction of Pfizer i.e., Pfizer and Barclays Capital go up and down completely randomly.

Pair Corralation between Pfizer and Barclays Capital

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Barclays Capital. In addition to that, Pfizer is 1.15 times more volatile than Barclays Capital. It trades about -0.06 of its total potential returns per unit of risk. Barclays Capital is currently generating about 0.18 per unit of volatility. If you would invest  5,764  in Barclays Capital on October 7, 2024 and sell it today you would earn a total of  1,435  from holding Barclays Capital or generate 24.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	20.36%
Values	Daily Returns

Pfizer Inc  vs.  Barclays Capital

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Barclays Capital

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Barclays Capital has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable forward-looking indicators, Barclays Capital is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Pfizer and Barclays Capital

The main advantage of trading using opposite Pfizer and Barclays Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Barclays Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Barclays Capital will offset losses from the drop in Barclays Capital's long position.

The idea behind Pfizer Inc and Barclays Capital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.